Effects of edaravone on oxidative protein modification and activity of gelatinases after intracerebral hemorrhage in rats with nicotinamide-streptozotocin induced diabetes
Open Access
- 15 December 2022
- journal article
- research article
- Published by PAGEPress Publications in Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
- Vol. 95 (2)
Abstract
Stroke, especially hemorrhagic form, is one of the most serious comorbidity disease of diabetes mellitus, often associated with high mortality, particularly in type 2 DM (T2DM). Therefore, it is relevant the search for drugs with a metabolically justified protective effect. Edaravone (Eda) is widely used for treating ischemic stroke but its biochemical effects in intracerebral hemorrhage (ICH) associated with T2DM is not still confirmed. The aim of the study was to assess the impact of Eda on the markers of oxidative modification of proteins (OMP), such as advanced oxidation protein products (AOPP), neutral and basic carbonyls (PC370 and PC430), advanced glycation end products (AGE) and ischemia modified albumin (IMA) as well as on the activity of matrix metalloproteinases MMP2/MMP9 (gelatinases) in rats with experimental T2DM after collagenase-induced ICH. Metformin was used as a comparative drug. The data obtained indicate that ICH in diabetic rats is accompanied by an increase in AOPP, PC370, AGE, and mature forms of both gelatinases. On the contrary, IMA and proMMP9 were below normal level after ICH. Both studied drugs decreased the OMP markers to the levels of intact rats or lower, and Eda show a more potent effect. Besides, Eda significantly decreased the activity of MMP9 and changed progelatinases activity. We conclude that Eda has a perspective to be useful in the treatment of comorbid brain hemorrhage in T2DM due to inhibiting of oxidative stress and modulation of gelatinases activity.Keywords
This publication has 28 references indexed in Scilit:
- The mechanisms of action of metforminDiabetologia, 2017
- The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular CalcificationJournal of Diabetes Research, 2016
- Edaravone offers neuroprotection for acute diabetic stroke patientsIrish Journal of Medical Science (1971 -), 2015
- Optimisation of an Advanced Oxidation Protein Products Assay: Its Application to Studies of Oxidative Stress in Diabetes MellitusOxidative Medicine and Cellular Longevity, 2015
- A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood–brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusionNeuroscience Letters, 2014
- Stroke and diabetes mellitus2014
- Edaravone Protected Human Brain Microvascular Endothelial Cells from Methylglyoxal-Induced Injury by Inhibiting AGEs/RAGE/Oxidative StressPLOS ONE, 2013
- Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography2012
- Timing of Serum Active MMP-9 and MMP-2 Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage2009
- [49] Determination of carbonyl content in oxidatively modified proteins1990